Comparison of the long term cardiac effects associated with 9 and 52 weeks of trastuzumab in HER2-positive early breast cancer

Sendur M. A. N., AKSOY S., YORGUN H., Ozdemir N., Yilmaz F. M., Yazici O., ...Daha Fazla

CURRENT MEDICAL RESEARCH AND OPINION, cilt.31, sa.3, ss.547-556, 2015 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1185/03007995.2015.1005834
  • Dergi Adı: CURRENT MEDICAL RESEARCH AND OPINION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.547-556
  • Anahtar Kelimeler: Breast cancer, HER2, Trastuzumab, Trastuzumab induced cardiotoxicity, LEFT-VENTRICULAR DYSFUNCTION, PLUS ADJUVANT CHEMOTHERAPY, RANDOMIZED-TRIAL, INDUCED CARDIOTOXICITY, FOLLOW-UP, DOXORUBICIN, BIOMARKERS, THERAPY, N9831, ERBB2
  • Gazi Üniversitesi Adresli: Hayır

Özet

Purpose: